drugset
drugset / Trial / NCT01421264

Gabapentin's Effects on Insomnia in Patients With Recent Concussion

NCT01421264 ↗

Phase 1 Completed 21 enrolled State University of New York at Buffalo
NaSingle-groupOpen-labelTreatment

Summary

In this open-label, pilot study the investigators will be assessing gabapentin's effects on insomnia and other concussion-related symptoms in patients with a recent concussion experiencing insomnia.

Timeline

Start
2011-08
Primary completion
2012-12
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 300 mg Oral

Indications

insomnia